Early Cancer Detection Test
We are excited to share that we now offer a revolutionary multi-cancer early detection test for our patients.
It’s called the Galleri Multi-Cancer Early-Detection Test* and it can detect more than 50 types of cancer by looking for signals in the blood that may be associated with cancer. (1,2) If caught in its early stages, cancer treatment outcomes and survival rates may be improved. (3)
Here are few benefits of the test:
It detects many cancers that are not commonly screened for today, so you can
get treated earlier.
It can be incorporated into a routine visit through a simple blood draw.
If a cancer signal is found, the results point to where in the body the cancer is
coming from to help us guide your next steps.
You can learn more about the test by watching a short explainer video.
Call our office, 928.300.1565, today and make an appointment to speak to a member of our team to discuss if the Galleri test may be right for you.
*The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. It is intended to be used in addition to, and not replace, other cancer screening tests.
Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test. Abstract LB013. Presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting April 10 – 15, 2021.
Amin MB, et al. (Eds). American Joint Committee of Cancer (AJCC) Cancer Staging Manual (8th edition)
Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data, Nov
2018 Sub. Includes persons aged 50-79 diagnosed 2006-2015 “Early/Localized” includes invasive localized tumors that have not spread beyond organ of origin, “Late/Metastasized” includes invasive cancers that have metastasized beyond the organ of origin to other parts of the body.